Thymosin Alpha-1
Documentation & standards
- How to Read a Peptide Certificate of Analysis (COA)
- Peptide Storage and Handling: Temperature, Light and Stability
- Research-Use-Only Compliance: What the Label Obligates
Thymosin Alpha-1 (Tα1) is a synthetic 28-amino-acid peptide of thymic origin, supplied for immunomodulation and T-cell / immune-signalling research endpoints.
Mix and match any items — discount applies automatically at checkout.
Earn 59 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for controlled laboratory receptor and pathway research.
What is Thymosin Alpha-1 (Tα1)?
Thymosin Alpha-1 — written Tα1 or TA1 — is a synthetic 28-amino-acid peptide corresponding to a sequence of thymic origin. The material supplied under this listing is produced synthetically and described here by its sequence and by the endpoints published research has examined.
Laboratory work with Thymosin Alpha-1 examines immunomodulation endpoints in defined experimental systems: Toll-like receptor engagement, T-cell differentiation and maturation markers, and cytokine-signalling readouts in cell-culture and animal models. It is structurally distinct from Thymalin, which the literature characterises as a thymic peptide preparation rather than a single isolated sequence, and from the unrelated Thymosin Beta-4 family. This page describes the compound and those studied endpoints only.
Thymosin Alpha-1 COA and batch verification
A Janoshik Analytical report dated June 2026 for Thymosin Alpha-1 10 mg is on file and displayed with this listing. Verification for research material supplied under this catalog follows the documented process: match the identifier on the received unit through the public batch lookup, and review the published verification standards before use.
Thymosin Alpha-1 research material specifications
| Compound | Thymosin Alpha-1 (Tα1, TA1) |
|---|---|
| Sequence | 28-amino-acid peptide of thymic origin, N-terminally acetylated |
| Class | Synthetic thymic peptide research material |
| Pathways studied | Toll-like receptor engagement and T-cell / immune-signalling readouts |
| Research focus | Immunomodulation endpoints, T-cell differentiation markers, cytokine-signalling measurements |
| Related structures | Distinct from Thymalin (thymic peptide preparation) and from Thymosin Beta-4 / TB-500 |
| Purity specification | ≥99% |
| Physical form | Lyophilized powder in a sealed glass vial |
| Available vial sizes | 5 mg, 10 mg |
| Attached report | Thymosin Alpha-1 10 mg — Janoshik Analytical (June 2026) |
| Storage | Refrigerated, dry, and protected from light; follow batch documentation |
Thymic peptide research context
Simonova MA et al., “Aging and Thymosin Alpha-1” (2025), PMID 41373628. Listed for thymic peptide research context only.
Thymosin Alpha-1 research questions
+What is Thymosin Alpha-1 (Tα1)?
Thymosin Alpha-1, abbreviated Tα1 and sometimes written TA1, is a synthetic 28-amino-acid peptide corresponding to a sequence of thymic origin. It is supplied here as laboratory research material described by its sequence and the endpoints published research has examined.
+Why is Thymosin Alpha-1 described as a thymic peptide?
Its sequence corresponds to a fragment first characterised from thymic tissue extracts, which is why the literature groups it with thymic peptides. The material offered here is produced synthetically rather than extracted.
+Which pathways are studied in Thymosin Alpha-1 research?
Published laboratory work examines immunomodulation endpoints — Toll-like receptor engagement, T-cell differentiation and maturation markers, and cytokine-signalling readouts — in defined cell-culture and animal models. This page describes those studied endpoints only.
+How does Thymosin Alpha-1 differ from Thymalin?
Thymosin Alpha-1 is a single defined 28-residue sequence. Thymalin is characterised in the literature as a thymic peptide preparation rather than one isolated sequence, so the two are studied as structurally distinct materials.
+Is a Thymosin Alpha-1 analytical report available?
Yes. A Janoshik Analytical report dated June 2026 for Thymosin Alpha-1 10 mg is on file and displayed with this listing. Researchers should still match the identifier on the received unit through the public batch lookup and review the published verification standards.
+Which Thymosin Alpha-1 formats are offered?
Thymosin Alpha-1 is supplied as sealed lyophilized research material in 5 mg and 10 mg vials. Current offers appear on this page.
+What is the listed purity specification?
The catalog specification is ≥99%. A specification is not the same as a batch result, so documentation associated with the received unit should be reviewed separately.
Read the Thymosin Alpha-1 research
Thymosin Alpha-1 (Tα1) is a synthetic 28-amino-acid thymic peptide. Overview of its sequence, receptor-signalling endpoints, and the limitations of the published record.
Read article →The defined 28-amino-acid Tα1 sequence, its acetylated N-terminus, and the Toll-like receptor and T-cell marker endpoints reported in laboratory work.
Read article →A structural and analytical comparison of Tα1, a defined 28-residue sequence, with Thymalin, a multi-component thymic peptide preparation.
Read article →Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.
Independent Certificate of Analysis
Independently tested by Janoshik Analytical. Verified and batch-tracked by Ares Research. Additional reports available upon request.
No fillers. No shortcuts. Only verified compounds.